Rare diseases
Investigational molecules
Locations
Study of Rilzabrutinib for Adults with Relapsed Immune Thrombocytopenia
CzechiaStudy on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency
CzechiaStudy of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy
CzechiaStudy Comparing Sonrotoclax and Zanubrutinib with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia
CzechiaStudy on the Effectiveness and Safety of LTP001 for Patients with Idiopathic Pulmonary Fibrosis
CzechiaStudy on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis
CzechiaLong-term Study of Zanubrutinib for Patients with B-cell Blood Cancer
CzechiaStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
CzechiaStudy of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy
CzechiaStudy of Zanubrutinib and Obinutuzumab for Patients with Relapsed or Refractory Follicular Lymphoma
CzechiaStudy on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
CzechiaStudy of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
